This is an unedited manuscript accepted for publication and provided as an Article in Press for early access at the author’s request. The article will undergo copyediting, typesetting, and galley proof review before final publication. Please be aware that errors may be identified during production that could affect the content. All legal disclaimers of the journal apply.
Journal Menu
By: .
Animal biotechnology has become a revolutionary subject that combines genetics,
farming, and medicine. It offers new ways to solve global problems like food security,
disease management, and drug manufacture. Scientists have used genetic
engineering, cloning, transgenesis, and genome editing to make livestock more
productive, generate animals that are immune to disease, and make useful scientific
models. Transgenic animals are also being utilised more and more to make
therapeutic proteins and help with research on organ transplants.
Animal biotechnology has many scientific and commercial benefits, but it also
presents difficult moral, environmental, and social questions. Concerns of animal
welfare, biodiversity, ecological balance, food safety, and the moral limits of genetic
tinkering need to be thought about very carefully. The responsible use of these
technologies is also heavily influenced by how the public sees them, the rules that
are in place, and their long-term viability.
This article talks about the scientific advances in animal biotechnology and the moral
issues that come up as a result. It stresses the necessity for fair policies, open
research processes, and ethical oversight to make sure that innovation moves
forward in a responsible and sustainable way.
Key words:
Genetic Engineering Animals with genes from other species Editing the Genome Animal Welfare • Bioethics Sustainable Farming
Citation:
Refrences:
[1] E. M. Hallerman, J. P. Bredlau, L. Sergio A. Camargo, M. Lucia Zaidan Dagli, et al. &Towards progressive regulatory approaches for agricultural applications of animal biotechnology,& 2022. ncbi.nlm.nih.gov
[2] J. L. Blanco and S. & Transgenic Animals" by Shantilal Ratanpara, 2012. https://digital.wpi.edu/
[3] B. Singh, G. Mal, S. K. Gautam, and M. Mukesh, & Intellectual Property Rights in Animal Biotechnology,& 2019. ncbi.nlm.nih.gov
[4] A. Fiester, & Casuistry and the Moral Continuum: Evaluating Animal Biotechnology,& 2007. V. Jans, W. Dondorp, E. Goossens, H. Mertes, and others wrote & Balancing animal welfare and assisted reproduction: ethics of preclinical animal research for testing new reproductive technologies,& 2018. ncbi.nlm.nih.gov
[6] L. Carbone, "Open Transparent Communication about Animals in Laboratories: Dialogue for Multiple Voices and Multiple Audiences,& 2021. ncbi.nlm.nih.gov
[7] S. Hartley and K. M. Millar, & The challenges of consulting the public on science policy: examining the development of European risk assessment policy for genetically modified animals,& 2014.
[8] R. Raymond Breault and T. Emmanuelle Torchon, & Transgenic Animals,& 2011. https://digital.wpi.edu/
[9] B. Trump, C. Cummings, K. Klasa, S. Galaitsi, et al. (2023). &Governing biotechnology to ensure safety and security while addressing ethical, legal, and social implications.& ncbi.nlm.nih.gov
[10] Y. Han, L. L. Fan, and Y. Xue, & A sustainable balance between innovation and risk: How the 'right to science' impacts China's medical biotechnology regulatory policy," 2024. ncbi.nlm.nih.gov
[11] V. Basil Hans, Biomedical Engineering and Biotechnology. International Journal of Industrial Biotechnology and Biomaterials. 2025; 11(2): 6–21p. You can find it at https://journalspub.com/publication/ijibb/article=21200.